Drachman Jonathan G Insider Trades

Insider Trading History

Track insider trading activity for Drachman Jonathan G. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $0 0 shares
Last Trade
Mar 11, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$328k 14,262 shares
$23.01
$23.01
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $125k 5,415 shares
Last Trade
Mar 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.55k 415 shares
$23.01
$23.01
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $115k 5,000 shares
Last Trade
Nov 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.7k 5,000 shares
$9.74
$23.01
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $529k 23,000 shares
Last Trade
Jun 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$153k 23,000 shares
$6.66
$23.01
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
President And CEO
Holding Value $1.22M 350,000 shares
Last Trade
Aug 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $234k 10,167 shares
Last Trade
Jun 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$204k 10,167 shares
$20.10
$23.01
Calithera Biosciences
Calithera Biosciences CALA
Director
Holding Value $60 200,000 shares
Last Trade
Nov 10, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.33M 200,000 shares
$16.64
$0.00
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
President And CEO
Holding Value $87.3k 25,000 shares
Last Trade
Aug 25, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
President And CEO
Holding Value $8.2M 2,348,686 shares
Last Trade
Aug 24, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
President And CEO
Holding Value $1.4M 400,000 shares
Last Trade
Aug 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Calithera Biosciences
Calithera Biosciences CALA
Director
Holding Value $6 20,000 shares
Last Trade
Jun 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$912k 20,000 shares
$45.60
$0.00
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
President And CEO
Holding Value $7.85M 2,248,686 shares
Last Trade
Jun 04, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
President And CEO
Holding Value $7.81M 2,238,686 shares
Last Trade
Jun 03, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$3.49
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $234k 10,167 shares
Last Trade
May 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.36M 10,167 shares
$232.00
$23.01
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $234k 10,167 shares
Last Trade
May 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.36M 10,167 shares
$232.00
$23.01
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
President And CEO
Holding Value $1.47M 420,000 shares
Last Trade
Aug 10, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Calithera Biosciences
Calithera Biosciences CALA
Director
Holding Value $6 20,000 shares
Last Trade
Jun 09, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.1M 20,000 shares
$105.00
$0.00
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $234k 10,167 shares
Last Trade
May 28, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.09M 10,167 shares
$205.90
$23.01
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $66.3k 2,880 shares
Last Trade
May 28, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$593k 2,880 shares
$205.90
$23.01
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
President And CEO
Holding Value $7.67M 2,198,686 shares
Last Trade
Dec 20, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$3.49

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up